0001209191-15-070557.txt : 20150914
0001209191-15-070557.hdr.sgml : 20150914
20150914172433
ACCESSION NUMBER: 0001209191-15-070557
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150910
FILED AS OF DATE: 20150914
DATE AS OF CHANGE: 20150914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STANLEY THEODORE H
CENTRAL INDEX KEY: 0000938296
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 151106216
MAIL ADDRESS:
STREET 1: 4745 WILEY POST WAY SUITE 650
STREET 2: C/O ANESTA CORP
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-10
0
0001516479
Insys Therapeutics, Inc.
INSY
0000938296
STANLEY THEODORE H
C/O INSYS THERAPEUTICS, INC.
444 SOUTH ELLIS STREET
CHANDLER
AZ
85224
1
0
0
0
Common Stock
2015-09-10
4
M
0
2000
3.63
A
4000
D
Common Stock
2015-09-10
4
S
0
1300
36.00
D
2700
D
Common Stock
2015-09-10
4
S
0
700
36.01
D
2000
D
Common Stock
2015-09-14
4
M
0
2000
3.63
A
4000
D
Common Stock
2015-09-14
4
S
0
2000
38.08
D
2000
D
Common Stock
6000
I
by non-profit corporation
Common Stock
10200
I
by limited partnership
Stock Option (right to buy)
3.63
2015-09-10
4
M
0
2000
0.00
D
2023-05-13
Common Stock
2000
38000
D
Stock Option (right to buy)
3.63
2015-09-14
4
M
0
2000
0.00
D
2023-05-13
Common Stock
2000
36000
D
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 1,000 additional shares.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 3,000 additional shares.
The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 5,100 additional shares.
The exercise price reflects a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.
On June 5, 2015, the Issuer effected a 2-for-1 forward stock split, resulting in the reporting person's ownership of 20,000 additional options.
/s/ Darryl S. Baker, Attorney-in-fact
2015-09-14